2026-2032年医疗塑胶挤出市场（按类型、应用和地区）

医疗塑胶挤出市场评估-2026-2032

由于对高性能、可靠医疗设备和零件的需求不断增加，医疗塑胶挤压市场正在成长。塑胶挤压成本低，且能够创造复杂的形状和设计，使其成为生产医用管、导管和其他关键部件的理想选择，预计到 2024 年市场规模将超过 9.0399 亿美元，到 2032 年将达到 12.2494 亿美元。

为了最大限度地减少医疗环境中的感染和交叉污染，人们越来越倾向于使用一次性医疗器械，这推动了对医用塑胶挤压的需求。注射器、静脉输液管和药物输送系统因其卫生优势而越来越受欢迎。随着全球医疗保健系统寻求更安全、更经济的替代品，医用塑胶提供了一种耐用且用途广泛的选择，推动市场在 2026 年至 2032 年期间以 4.27% 的复合年增长率增长。

医疗塑胶挤压市场定义/概述

医用塑胶挤出是一种将塑胶材料形成连续型材以生产各种医疗设备和零件的专门製造方法。将 PVC、聚乙烯和聚丙烯等医用级塑胶熔化并透过专门设计的晶粒压制，以形成管材、导管和鞘套等精确的形状。挤压方法具有高精度和一致性，这对于公差要求严格的医疗应用和必须符合严格安全和监管标准的产品至关重要。

它通常用于製造各种医疗设备，包括导管、管材和手术器械。该技术涉及将高品质聚合物熔化和模塑成符合严格医疗要求的精确、可客製化的形式。

由于对微创治疗和改进的医疗设备的需求不断增加，预计医疗塑胶挤压的使用将会成长。医疗保健技术的进步正在推动对能够满足医疗应用严格要求的高性能、生物相容性塑胶的需求。新型聚合物材料，特别是生物可吸收聚合物的开发，将提高挤压技术的能力，从而生产出在达到目的后能够安全溶解在体内的设备。

微创手术需求的不断增长是否会推动医疗塑胶挤压市场的发展？

医疗塑胶挤压市场正在迅速扩张，主要受微创手术需求不断增长的推动。这一发展正在极大地改变医疗保健行业，并为医疗塑胶挤压製造商提供了巨大的前景。微创手术的日益增长的趋势是医疗塑胶挤压行业的主要推动力。根据美国疾病管制与预防中心（CDC）国家健康统计报告，2006年至2018年间，美国门诊手术就诊人次增加了32.8%，从1,190万人次增至1,580万人次。

《美国医学会杂誌》（JAMA）发表的一项研究发现，与开放性手术相比，微创手术平均可减少住院时间2.4天。较短的恢復时间将影响病患的偏好和医院的采用。此外，对导管手术的需求也在不断增长，这类手术通常涉及医用塑胶的挤压。根据美国心臟协会统计，美国每年进行约一百万例心导管插入术。

高材料成本会阻碍医疗塑胶挤出市场吗？

材料成本上升可能是医疗塑胶挤压市场扩张的一大障碍。聚氯乙烯(PVC)、聚乙烯和聚丙烯等医用塑胶通常成本较高，因为它们必须遵守严格的监管要求以确保安全性和生物相容性。这些塑胶必须符合较高的医疗标准，因此生产成本很高。因此，生产商将努力满足对高品质、低成本医疗用品的需求，同时保持获利。

材料成本的上升可能会限制生产导管、管材和其他医疗保健设备等复杂医疗部件所需的先进挤压技术的使用。规模较小的製造商可能难以承担优质原料带来的成本增加，并可能失去市场竞争力。这些高成本也可能转嫁给医疗保健提供者，从而增加医疗设备的价格并降低患者的负担能力。

目录

第一章全球医用塑胶挤出市场介绍

• 市场概览
• 研究范围
• 先决条件

第二章执行摘要

第三章：已验证的市场研究调查方法

• 资料探勘
• 验证
• 第一手资料
• 资料来源列表

第四章全球医疗塑胶挤出市场展望

• 概述
• 市场动态
  • 驱动程式
  • 限制因素
  • 机会
• 波特五力模型
• 价值链分析

第五章全球医用塑胶挤出市场（按类型）

• 概述
• 医用导管
• 其他的

6 全球医疗塑胶挤压市场（按应用）

• 概述
• 医院
• 诊所
• 其他的

7. 全球医疗塑胶挤压市场（按地区）

• 概述
• 北美洲
  • 美国
  • 加拿大
  • 墨西哥
• 欧洲
  • 德国
  • 英国
  • 法国
  • 其他欧洲国家
• 亚太地区
  • 中国
  • 日本
  • 印度
  • 其他亚太地区
• 其他的
  • 拉丁美洲
  • 中东和非洲

第八章全球医疗塑胶挤出市场竞争格局

• 概述
• 各公司市场排名
• 重点发展策略

第九章 公司简介

• Vesta
• Vention Medical
• Putnam Plastics
• Pexco
• Raumedic
• Fluortek
• VistaMed
• Teel Plastics
• Biomerics
• AP Extrusion
• 3M
• GSH Industries
• Nenplas Ltd
• Saint Gobain
• Atlantis Plastics, Inc.
• Keller Plastics, Inc.
• China Plastic Extrusion Ltd

第十章 附录

• 相关调查

Medical Plastics Extrusion Market Valuation - 2026-2032

The medical plastics extrusion market is rising in response to the growing demand for high-performance, dependable medical devices and components. Plastic extrusion is a low-cost procedure that allows for the creation of complicated shapes and designs making it perfect for producing medical tubing, catheters, and other vital components by enabling the market to surpass a revenue of USD 903.99 Million valued in 2024 and reach a valuation of around USD 1224.94 Million by 2032.

The trend toward single-use medical devices to minimize infections and cross-contamination in healthcare environments drives up demand for medical plastics extrusion. Syringes, IV tubes, and drug delivery systems are becoming more popular due to their sanitary benefits. As healthcare systems around the world seek safer and more economical alternatives, medical plastics offer a durable and versatile option by enabling the market to grow at a CAGR of 4.27 % from 2026 to 2032.

Medical Plastics Extrusion Market: Definition/ Overview

Medical plastic extrusion is a specialized manufacturing method that shapes plastic materials into continuous profiles to create a variety of medical devices and components. Medical-grade plastics such as PVC, polyethylene, and polypropylene are melted and pressed through a specially designed die to make precise geometries such as tubes, catheters, and sheaths. The extrusion method provides high precision and consistency which is crucial for medical applications with tight tolerances and products that must fulfill demanding safety and regulatory criteria.

It is commonly used in the manufacture of a variety of medical devices such as catheters, tubing, and surgical tools. The technique entails melting and sculpting high-quality polymers into precise, customizable shapes that meet strict medical requirements.

The use of medical plastic extrusion is predicted to grow in response to increased demand for minimally invasive treatments and improved medical gadgets. As healthcare technologies advance, there is a growing demand for high-performance, biocompatible plastics that can withstand the harsh demands of medical applications. The development of novel polymer materials, especially bioresorbable polymers, is likely to improve the capabilities of extrusion technologies allowing the manufacturing of devices that can safely dissolve within the body once they have served their purpose.

Will the Rising Demand for Minimally Invasive Procedures Drive the Medical Plastics Extrusion Market?

The medical plastics extrusion market is expanding rapidly driven mostly by rising demand for minimally invasive procedures. This development is altering the healthcare industry presenting significant prospects for medical plastic extruders. The growing inclination for minimally invasive procedures is a major driver for the medical plastics extrusion industry as evidenced by compelling statistics. According to the Centers for Disease Control and Prevention's (CDC) National Health Statistics Reports, the number of ambulatory surgery visits in the United States increased by 32.8% between 2006 and 2018, from 11.9 million to 15.8 million.

A study published in the Journal of the American Medical Association (JAMA) discovered that minimally invasive procedures cut hospital stays by an average of 2.4 days when compared to open surgeries. This shorter recuperation time influences patient preferences and hospital adoption. The need for catheter-based procedures which frequently involve extruded medical plastics is also increasing. According to the American Heart Association, there are roughly 1 million cardiac catheterizations conducted in the United States each year.

Will the High Material Costs Hamper the Medical Plastics Extrusion Market?

High material costs may constitute a substantial barrier to the expansion of the medical plastics extrusion market. Medical-grade plastics such as polyvinyl chloride (PVC), polyethylene, and polypropylene are frequently costly due to the stringent regulatory requirements they must follow to ensure safety and biocompatibility. These plastics must meet high medical standards which increases production costs. As a result, producers may struggle to remain profitable while meeting demand for high-quality, low-cost medical items.

Rising material costs may limit the usage of advanced extrusion technologies which are required for the production of complicated medical components such as catheters, tubing, and other healthcare devices. Smaller manufacturers may struggle to absorb the increased costs associated with premium raw materials resulting in lost market competitiveness. These high expenses may also be passed on to healthcare providers, thereby raising the price of medical devices and reducing patient affordability.

Category-Wise Acumens

Will Rising Demand for Intravenous Medication Drive Growth in the Type Segment?

The medical tubing segment is predicted to experience the greatest increase in the medical plastics extrusion market during the forecasted period. The growing use of catheters and other medical equipment needs flexible, long-lasting tubing which is driving this increase. Furthermore, the increased prevalence of chronic diseases and an aging population are driving up demand for various medical equipment, accelerating the growth of the medical tubing segment.

Medical tubing is essential in IV administration because it allows fluids, nutrients, and drugs to be delivered safely and efficiently directly into the bloodstream. The growing use of IV therapies in hospitals and at home has created a substantial need for dependable and flexible medical tubing. Furthermore, advances in plastic materials such as the creation of PVC alternatives and antimicrobial coatings have improved the adaptability and safety of tubing for a wide range of medical uses.

Will the Increasing Use of Extruded Plastics Drive the Application Segment?

Hospitals, clinics, and other healthcare facilities make up the application sector of the medical plastics extrusion market. Hospitals are predicted to enjoy the most substantial growth over the projection period. The increasing demand for medical devices and consumables such as needle and syringe caps, tubing, catheters, and other extruded plastic components is a major driver of this growth. These products are essential for daily operations in hospitals where a high number of medical procedures and patient care activities occur.

The growing need for high-quality healthcare services is encouraging the use of modern medical technologies in hospitals such as extruded plastic components. These plastics have high resilience and flexibility, and they are simple to clean and sterilize making them perfect for usage in a variety of medical environments where hygiene and patient safety are critical. The growing emphasis on infection control and patient safety combined with rising healthcare spending in many places is likely to drive up demand for extruded plastic goods in hospitals positioning this industry for significant growth in the future years.

Country/Region-wise Acumens

Will Growing Healthcare Infrastructure Drive the Market in the Asia Pacific Region?

The Asia Pacific region is expected to become the dominating market for medical plastics extrusion owing to its rapidly increasing healthcare infrastructure. This expansion is especially notable in emerging markets such as China, India, and Southeast Asian countries.

The growing healthcare infrastructure in the Asia Pacific region is a key driver of the medical plastics extrusion market as evidenced by compelling statistics. According to the World Health Organization (WHO), healthcare spending in the Western Pacific Region which encompasses much of East Asia, rose from 6.4% of GDP in 2000 to 6.9% in 2018.

The region's aging population and increased chronic disease prevalence are also driving growth in the medical plastics extrusion market. The United Nations predicts that the number of persons aged 65 and up in Asia will rise from 395 million in 2020 to 954 million by 2050. Furthermore, the International Diabetes Federation predicts that the number of adults with diabetes in Southeast Asia will increase from 88 million in 2019 to 153 million by 2045. These demographic transitions and health trends drive demand for different medical equipment including catheters, tubing, and drug delivery systems which frequently use extruded medical plastics.

Will Advanced Technical Specification Drive the Market in the North American Region?

North America is predicted to be the fastest-growing region in the medical plastics extrusion market owing to its sophisticated technical specifications and high-quality standards. This rapid expansion is being driven by the region's strong healthcare infrastructure, major R&D investments, and rising demand for novel medical devices. Advanced technical criteria are propelling the medical plastics extrusion market in North America. As of 2021, the United States Food and Drug Administration (FDA) reported 6,954 registered medical device manufacturing establishments, many of which used advanced plastic extrusion processes.

The National Institutes of Health (NIH) budget for medical research reached USD 41.7 Billion in 2020, promoting breakthroughs that frequently result in new medical devices requiring complex plastic components. Furthermore, the US Bureau of Labor Statistics predicts a 5% increase in job opportunities for medical scientists from 2019 to 2029 faster than the average for all occupations reflecting continued research and development in the sector. The drive of downsizing in medical equipment with some components having dimensions as small as 0.10 mm, tests the limits of plastic extrusion technology.

Competitive Landscape

The Medical Plastics Extrusion Market is a dynamic and competitive space, characterized by a diverse range of players vying for market share. These players are on the run for solidifying their presence through the adoption of strategic plans such as collaborations, mergers, acquisitions, and political support. The organizations are focusing on innovating their product line to serve the vast population in diverse regions.

Some of the prominent players operating in the medical plastics extrusion market include:

GSH Industries

Nenplas Ltd

Saint Gobain

Atlantis Plastics, Inc.

Keller Plastics, Inc.

China Plastic Extrusion Ltd

Vesta

Teel Plastic

3M

Biomerics

In November 2023, Davis-Standard announced in November 2023 that it would acquire the Extrusion Technology Group (ETG) from entities controlled by Dutch investor Nimbus. This acquisition aligns with Davis-Standard's commitment to providing top-tier extrusion equipment and converting systems, as well as comprehensive aftermarket support.

In April 2023, Wellspect HealthCare announced a significant development in its product line when the company introduced bio-attributed raw materials into one of its offerings, specifically the LoFric Elle female urinary catheter. This is significant in an industry that has traditionally relied on fossil-based plastics, signaling a significant step forward for medical device manufacturers who prioritize sustainable and bio-sourced materials.

Medical Plastics Extrusion Market, By Category

• Type:
• Medical Tubing
• Other
• Application:
• Hospital
• Clinic
• Other
• Region:
• North America
• Europe
• Asia-Pacific
• South America
• Middle East & Africa

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL MEDICAL PLASTICS EXTRUSION MARKET

• 1.1 Overview of the Market
• 1.2 Scope of Report
• 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

• 3.1 Data Mining
• 3.2 Validation
• 3.3 Primary Interviews
• 3.4 List of Data Sources

4 GLOBAL MEDICAL PLASTICS EXTRUSION MARKET OUTLOOK

• 4.1 Overview
• 4.2 Market Dynamics
  • 4.2.1 Drivers
  • 4.2.2 Restraints
  • 4.2.3 Opportunities
• 4.3 Porters Five Force Model
• 4.4 Value Chain Analysis

5 GLOBAL MEDICAL PLASTICS EXTRUSION MARKET, BY TYPE

• 5.1 Overview
• 5.2 Medical Tubing
• 5.3 Other

6 GLOBAL MEDICAL PLASTICS EXTRUSION MARKET, BY APPLICATION

• 6.1 Overview
• 6.2 Hospital
• 6.3 Clinic
• 6.4 Other

7 GLOBAL MEDICAL PLASTICS EXTRUSION MARKET, BY GEOGRAPHY

• 7.1 Overview
• 7.2 North America
  • 7.2.1 U.S.
  • 7.2.2 Canada
  • 7.2.3 Mexico
• 7.3 Europe
  • 7.3.1 Germany
  • 7.3.2 U.K.
  • 7.3.3 France
  • 7.3.4 Rest of Europe
• 7.4 Asia Pacific
  • 7.4.1 China
  • 7.4.2 Japan
  • 7.4.3 India
  • 7.4.4 Rest of Asia Pacific
• 7.5 Rest of the World
  • 7.5.1 Latin America
  • 7.5.2 Middle East and Africa

8 GLOBAL MEDICAL PLASTICS EXTRUSION MARKET COMPETITIVE LANDSCAPE

• 8.1 Overview
• 8.2 Company Market Ranking
• 8.3 Key Development Strategies

9 COMPANY PROFILES

• 9.1 Vesta
  • 9.1.1 Overview
  • 9.1.2 Financial Performance
  • 9.1.3 Product Outlook
  • 9.1.4 Key Developments
• 9.2 Vention Medical
  • 9.2.1 Overview
  • 9.2.2 Financial Performance
  • 9.2.3 Product Outlook
  • 9.2.4 Key Developments
• 9.3 Putnam Plastics
  • 9.3.1 Overview
  • 9.3.2 Financial Performance
  • 9.3.3 Product Outlook
  • 9.3.4 Key Developments
• 9.4 Pexco
  • 9.4.1 Overview
  • 9.4.2 Financial Performance
  • 9.4.3 Product Outlook
  • 9.4.4 Key Developments
• 9.5 Raumedic
  • 9.5.1 Overview
  • 9.5.2 Financial Performance
  • 9.5.3 Product Outlook
  • 9.5.4 Key Developments
• 9.6 Fluortek
  • 9.6.1 Overview
  • 9.6.2 Financial Performance
  • 9.6.3 Product Outlook
  • 9.6.4 Key Developments
• 9.7 VistaMed
  • 9.7.1 Overview
  • 9.7.2 Financial Performance
  • 9.7.3 Product Outlook
  • 9.7.4 Key Developments
• 9.8 Teel Plastics
  • 9.8.1 Overview
  • 9.8.2 Financial Performance
  • 9.8.3 Product Outlook
  • 9.8.4 Key Developments
• 9.9 Biomerics
  • 9.9.1 Overview
  • 9.9.2 Financial Performance
  • 9.9.3 Product Outlook
  • 9.9.4 Key Developments
• 9.10 A.P. Extrusion
  • 9.10.1 Overview
  • 9.10.2 Financial Performance
  • 9.10.3 Product Outlook
  • 9.10.4 Key Developments
• 9.11 3M
  • 9.11.1 Overview
  • 9.11.2 Financial Performance
  • 9.11.3 Product Outlook
  • 9.11.4 Key Developments
• 9.12 GSH Industries
  • 9.12.1 Overview
  • 9.12.2 Financial Performance
  • 9.12.3 Product Outlook
  • 9.12.4 Key Developments
• 9.13 Nenplas Ltd
  • 9.13.1 Overview
  • 9.13.2 Financial Performance
  • 9.13.3 Product Outlook
  • 9.13.4 Key Developments
• 9.14 Saint Gobain
  • 9.14.1 Overview
  • 9.14.2 Financial Performance
  • 9.14.3 Product Outlook
  • 9.14.4 Key Developments
• 9.15 Atlantis Plastics, Inc.
  • 9.15.1 Overview
  • 9.15.2 Financial Performance
  • 9.15.3 Product Outlook
  • 9.15.4 Key Developments
• 9.16 Keller Plastics, Inc.
  • 9.16.1 Overview
  • 9.16.2 Financial Performance
  • 9.16.3 Product Outlook
  • 9.16.4 Key Developments
• 9.17 China Plastic Extrusion Ltd
  • 9.17.1 Overview
  • 9.17.2 Financial Performance
  • 9.17.3 Product Outlook
  • 9.17.4 Key Developments

10 Appendix

• 10.1 Related Research